findmyKOL
Clinical trialNCT06429735RecruitingInterventional

Precise Robotically IMplanted Brain-Computer InterfacE

SponsorNeuralink CorpEnrollment15Amyotrophic Lateral SclerosisCervical Spinal Cord InjuryQuadriplegiaQuadriplegia/TetraplegiaTetraplegia/TetraparesisTetraplegic; Paralysis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Barrow Neurological Institute

    Phoenix, Arizona, United States

    Francisco Ponce, MD
    Recruiting
  • University of Miami

    Miami, Florida, United States

    Jonathan Jagid, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Jan 2024
Primary completion
30 Jun 2026
Completion
31 Jan 2031
Last update posted
9 Jan 2026
Registered enrollment
15
Registry id
NCT06429735

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.